|
1 Indications And Usage Oriahnn Is Indicated For The Management Of Heavy Menstrual Bleeding Associated With Uterine Leiomyomas (Fibroids) In Premenopausal Women. Limitation Of Use: Use Of Oriahnn Should Be Limited To 24 Months Due To The Risk Of Continued Bone Loss, Which May Not Be Reversible [See Dosage And Administration (2.1) And Warnings And Precautions (5.2) ] . Oriahnn Is A Combination Of Elagolix, A Gonadotropin-Releasing Hormone (Gnrh) Receptor Antagonist, Estradiol, An Estrogen, And Norethindrone Acetate, A Progestin, Indicated For The Management Of Heavy Menstrual Bleeding Associated With Uterine Leiomyomas (Fibroids) In Premenopausal Women. ( 1 ) Limitation Of Use: Use Of Oriahnn Should Be Limited To 24 Months Due To The Risk Of Continued Bone Loss, Which May Not Be Reversible. (1)
|